Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Argenica Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Cancer drug developer Chimeric heads to blood bank for better patient cells
Health & Biotech
ASX stocks leading clinical trials in Australia
Health & Biotech
Australia proves its reputation as ‘go-to’ destination for clinical trials
News
Market Highlights: Tesla, Alphabet slump after posting results, and 5 ASX small caps to watch today
Health & Biotech
Beyond Resources Part 2: ASX companies driving WA’s medical and life sciences sector
Health & Biotech
The ASX biotechs with secured FDA clearances in 2024, and others looking likely
News
ASX Small Caps and IPO Weekly Wrap: The ASX is fired up and feisty as metals make a comeback
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Budget lifts explorers, market newbie Sun Silver up 125pc on debut
Health & Biotech
ASX Health Stocks: Argenica’s traumatic brain injury drug works well in animal model
News
Market Highlights: Diggers in focus after Budget boost; Anglo fends off BHP by selling assets
News
Rise and Shine: Everything you need to know before the ASX opens
News
Market Highlights: Bullish predictions on gold and copper prices, and 5 ASX small caps to watch today
News
ASX Small Caps and IPO Weekly Wrap: Goldies ruled the roost as we got teased by a 10-bagger
News
Closing Bell: ASX soars as gold, iron ore and lithium miners all rise; Vanguard guilty of greenwashing
News
ASX Small Caps Lunch Wrap: Have US investors gone a bit meme-stock mad this week?
Health & Biotech
